Boston Scientific settles global heart valve legal battles for $180M
January 15, 2019 at 14:40 PM EST
The tools Boston Scientific and Edwards Lifesciences have battled over are used during a relatively new, multibillion-dollar cardiac treatment called transcatheter aortic valve replacement (TAVR).